Personalis Revenue 2018-2024 | PSNL
Personalis revenue from 2018 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Personalis Annual Revenue
(Millions of US $) |
| 2023 |
$73 |
| 2022 |
$65 |
| 2021 |
$85 |
| 2020 |
$79 |
| 2019 |
$65 |
| 2018 |
$38 |
| 2017 |
$9 |
Personalis Quarterly Revenue
(Millions of US $) |
| 2024-09-30 |
$26 |
| 2024-06-30 |
$23 |
| 2024-03-31 |
$20 |
| 2023-12-31 |
$20 |
| 2023-09-30 |
$18 |
| 2023-06-30 |
$17 |
| 2023-03-31 |
$19 |
| 2022-12-31 |
$17 |
| 2022-09-30 |
$15 |
| 2022-06-30 |
$18 |
| 2022-03-31 |
$15 |
| 2021-12-31 |
$21 |
| 2021-09-30 |
$22 |
| 2021-06-30 |
$22 |
| 2021-03-31 |
$21 |
| 2020-12-31 |
$20 |
| 2020-09-30 |
$20 |
| 2020-06-30 |
$19 |
| 2020-03-31 |
$19 |
| 2019-12-31 |
$18 |
| 2019-09-30 |
$17 |
| 2019-06-30 |
$16 |
| 2019-03-31 |
$14 |
| 2018-12-31 |
|
| 2018-09-30 |
$12 |
| 2018-06-30 |
$9 |
| 2017-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.261B |
$0.073B |
|
Personalis Inc. is a cancer genomics company. It is engaged in the development of therapies by providing molecular data about each patient's cancer and immune response. Personalis Inc. is based in Menlo Park, California.
|
